Related Experiment Video
Updated: Aug 8, 2026
Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
A method for detecting specific anti-C100 protein antibodies of IgM isotype in hepatitis C virus infection
1Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Italy.
Insights
A new method accurately detects specific IgM antibodies to hepatitis C virus (HCV) C100 antigen. This IgM anti-C100 marker may indicate active HCV infection and disease progression.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Hepatitis C virus (HCV) infection is a significant global health concern.
- Accurate diagnostic markers for active HCV infection are crucial for patient management.
- Specific antibody detection aids in understanding disease pathogenesis and progression.
Purpose of the Study:
- To develop and validate a method for determining specific IgM antibodies against the C100 protein of HCV.
- To assess the diagnostic utility of IgM anti-C100 in patients with chronic liver disease.
- To correlate the presence of IgM anti-C100 with disease activity and histological findings.
Main Methods:
- Serum protein fractionation using gel chromatography.
- Enzyme-linked immunosorbent assay (ELISA) for antibody detection.
- Separation of IgM from IgG antibodies to ensure specificity.
Main Results:
- A specific and reproducible method for detecting IgM anti-C100 was established.
- IgM antibody detection required prior separation from IgG antibodies.
- IgM anti-C100 was detected in 44% of patients with chronic liver disease.
- The presence of IgM anti-C100 correlated with more progressive liver disease stages.
Conclusions:
- IgM antibodies to the C100 antigen are specific markers for HCV infection.
- The detection of IgM anti-C100 may serve as an indicator of active hepatitis C virus infection.
- This marker shows potential for assessing disease activity in chronic liver disease patients.
Abstract:
A method for the determination of specific IgM antibodies to C100 protein, a hepatitis C virus-associated antigen, was developed which employed fractionation of serum proteins by gel chromatography and an enzyme-linked immunosorbent assay. Detection of IgM anti-C100 proved to be specific and reproducible in purified IgM fractions. Separation of IgM from IgG was necessary before IgM could be measured, because of the detrimental effect of the simultaneous presence of IgG antibodies with anti-C100 rectivity on IgM determination. IgM anti-C100 was not found in sera containing rheumatoid factors or IgM antibodies to other hepatotropic viruses. IgM anti-C100 was detected in 19 (44%) of 43 patients with hepatitis C virus-related chronic liver disease. When compared with the histological picture of liver disease, IgM anti-C100 was absent in patients with minimal changes and was most common (66.7%) in patients with progressive disease. It is suggested that IgM anti-C100 could reflect an active state of hepatitis C virus infection.
